Revenio Group Oyj

Director's Dealing • Feb 16, 2023

Revenio Group Corporation: Managers' Transactions –John Floyd

Revenio Group Corporation, Managers' transactions, February 16, 2023 at 4.00 p.m. (EET)

Revenio Group Oyj - Managers' Transactions –John Floyd

Person subject to the notification requirement Name: John Floyd Position: Other senior manager

Issuer: Revenio Group Oyj LEI: 743700I27E0FWSXLKK04 Notification type: INITIAL NOTIFICATION Reference number: 25540/7/6

Transaction date: 2023-02-15 Outside a trading venue Instrument type: SHARE ISIN: FI0009010912 Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE

Transaction details (1): Volume: 1496 Unit price: 0 EUR Aggregated transactions (1): Volume 1496 Volume weighted average price: 0 EUR

For further information, please contact

CFO Robin Pulkkinen, tel. +358 50 505 9932 robin.pulkkinen@revenio.fi www.revenio.fi

Distribution Nasdaq Helsinki FIN-FSA Key media www.revenio.fi/en

Revenio Group in brief

Revenio is a leading company in the global market for ophthalmological devices and software solutions. Revenio's ophthalmic diagnostic solutions include intraocular pressure (IOP) measurement devices (tonometers), fundus imaging devices, and perimeters as well as clinical

software under the iCare brand. iCare is a trusted partner in ophthalmic diagnostics, offering physicians fast, easy-to-use, and reliable tools for the diagnosis of glaucoma, diabetic retinopathy, and macular degeneration (AMD). iCare Solutions provide digital clinical tools that drive greater efficiency and enhance quality in eye care.

In 2022, the Group's net sales totaled EUR 97.0 million, with an operating profit of EUR 29.7 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.

Attachments

Revenio Group Corporation: Managers' Transactions –John Floyd